Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV Vaccines Immunogenicity and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00231413
What this trial is testing

Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 383
Large-scale testing (Phase 3)Looking for participantsNCT04422366
What this trial is testing

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 8,000
Large-scale testing (Phase 3)Study completedNCT00092547
What this trial is testing

Gardasil (V501) in Preadolescents and Adolescents (V501-018)

Who this might be right for
HumanPapillomavirus Infections
Merck Sharp & Dohme LLC 1,781
Early research (Phase 1)Looking for participantsNCT05985681
What this trial is testing

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

Who this might be right for
Human Papillomavirus-Related Carcinoma
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Active Not RecruitingNCT06281119
What this trial is testing

Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years

Who this might be right for
Human Papillomavirus Infection
Serum Institute of India Pvt. Ltd. 450
Early research (Phase 1)Study completedNCT00549900
What this trial is testing

A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Study completedNCT00359619
What this trial is testing

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 383